Suppr超能文献

昆士兰黑色素瘤家族人群样本中的CDKN2A基因变异

CDKN2A variants in a population-based sample of Queensland families with melanoma.

作者信息

Aitken J, Welch J, Duffy D, Milligan A, Green A, Martin N, Hayward N

机构信息

Queensland Institute of Medical Research, Brisbane, Australia.

出版信息

J Natl Cancer Inst. 1999 Mar 3;91(5):446-52. doi: 10.1093/jnci/91.5.446.

Abstract

BACKGROUND

Mutations in the CDKN2A gene confer susceptibility to cutaneous malignant melanoma (CMM); however, the population incidence of such mutations is unknown. Polymorphisms in CDKN2A have also been described, but it is not known whether they influence melanoma risk. We investigated the association of CDKN2A mutations and polymorphisms with melanoma risk in a population-based sample of families ascertained through probands with melanoma.

METHODS

The 482 Queensland, Australia, families in our sample were characterized previously as having high, intermediate, or low family risk of CMM. Unrelated individuals (n = 200 families/individuals) drawn from the Australian Twin Registry served as control subjects. For individuals in the high-risk group, the entire CDKN2A gene coding region was screened for mutations by use of the polymerase chain reaction, agarose gel electrophoresis, allele-specific oligonucleotide (ASO) hybridization, and single-strand conformation polymorphism analysis. The intermediate- and low-risk families and control subjects were analyzed by ASO hybridization for a total of six recurring mutations as well as for polymorphisms at nucleotides (Nts) 442, 500, and 540.

RESULTS

CDKN2A mutations were found only in the high-risk families (nine [10.3%] of 87). The prevalence of the Nt500G (guanosine) polymorphism increased linearly with increasing familial risk (two-sided P = .02) and was highest in the nine (primarily Celtic) families with CDKN2A mutations. After adjustment for ethnic origin, the relationship between risk group and the frequency of the Nt500G allele was weakened (P = .25); however, there was no relationship between ethnic origin and Nt500-polymorphism frequency among the control subjects.

CONCLUSIONS

CDKN2A mutations are rare in this population (approximately 0.2% of all melanoma cases in Queensland) and appear to be associated with melanoma in only the most affected families. The Nt500G allele appears to be associated with familial risk, but this association probably reflects Celtic ancestry.

摘要

背景

CDKN2A基因的突变会使人易患皮肤恶性黑色素瘤(CMM);然而,此类突变在人群中的发生率尚不清楚。CDKN2A基因的多态性也已被描述,但尚不清楚它们是否会影响黑色素瘤风险。我们通过以黑色素瘤先证者确诊的基于人群的家系样本,研究了CDKN2A基因的突变和多态性与黑色素瘤风险之间的关联。

方法

我们样本中的482个澳大利亚昆士兰家庭先前被分类为具有高、中或低CMM家族风险。从澳大利亚双胞胎登记处抽取的无血缘关系个体(n = 200个家庭/个体)作为对照。对于高危组中的个体,通过聚合酶链反应、琼脂糖凝胶电泳、等位基因特异性寡核苷酸(ASO)杂交和单链构象多态性分析,对整个CDKN2A基因编码区进行突变筛查。对中低风险家庭和对照个体通过ASO杂交分析总共六个复发性突变以及核苷酸(Nts)4​​42、500和540处的多态性。

结果

仅在高危家庭中发现了CDKN2A基因突变(87个家庭中有9个[10.3%])。Nt500G(鸟苷)多态性的患病率随家族风险增加呈线性增加(双侧P = 0.02),在9个携带CDKN2A基因突变的家庭(主要是凯尔特人家庭)中最高。在调整种族起源后,风险组与Nt500G等位基因频率之间的关系减弱(P = 0.25);然而,对照个体的种族起源与Nt500多态性频率之间没有关系。

结论

CDKN2A基因突变在该人群中很少见(约占昆士兰所有黑色素瘤病例的0.2%),并且似乎仅与受影响最严重的家庭中的黑色素瘤有关。Nt500G等位基因似乎与家族风险有关,但这种关联可能反映了凯尔特人的血统。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验